eicosapentaenoic acid ethyl ester has been researched along with Lipodystrophy in 1 studies
Lipodystrophy: A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Congenital generalized lipodystrophy type 4 (CGL4) is a rare autosomal recessive condition with high rates of morbidity and mortality." | 1.72 | Successful treatment of severe hypertriglyceridemia with icosapent ethyl in a case of congenital generalized lipodystrophy type 4. ( Babalola, F; Bulic, A; Curtis, J; Ng, D, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babalola, F | 1 |
| Ng, D | 1 |
| Bulic, A | 1 |
| Curtis, J | 1 |
1 other study available for eicosapentaenoic acid ethyl ester and Lipodystrophy
| Article | Year |
|---|---|
Successful treatment of severe hypertriglyceridemia with icosapent ethyl in a case of congenital generalized lipodystrophy type 4.
Topics: Adolescent; Eicosapentaenoic Acid; Female; Humans; Hypertriglyceridemia; Lipodystrophy; Lipodystroph | 2022 |